GSK Investigational Site

Cullman, Alabama 35058

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Multiple Sclerosis

Studies at this site

• Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19 — Stopped early
• Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis — Completed